An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody ...

As described previously, during the national vaccination campaign against rubella started in May 2001 in Costa Rica, in which the MR vaccine was administered to all men and women between 15 and 39 ...

More information: William N. Voss et al, Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination, Cell Reports Medicine (2024).

A contagious viral infection characterized by its distinctive red rash. It is caused by rubella virus. Transmitted through the air by respiratory droplets (from coughing or sneezing). Common ...

If the tests detect novel coronavirus antigens, the antibodies used in the test will bind to them and produce a positive test result. Doctors collect samples for the test using a nasal swab.

Prevention of Measles, Rubella, Congenital Rubella Syndrome and ... With no documentation of disease, a Varicella IgG antibody blood titer is required. If VZVIgG positive, no additional vaccines ...

Asymptomatic infants are considered at risk if the mother's nontreponemal and treponemal serologies are positive ... infants have VZV-specific IgM and IgG antibodies detectable in the cord ...

A study found that breast milk provides protection against rotavirus, a common gastrointestinal disease that causes diarrhea, vomiting and fever in infants. Babies whose mothers had high levels of ...

This new method, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, uses tumour-specific profiling to detect antibodies unique to stage I and II melanoma patients.

Antibodies are proteins that circulate in the blood and protect against foreign antigenic substances such as bacteria, viruses, fungi, parasites, chemicals, or toxins. They are Y-shaped structures ...

Treatment with the antibody-drug conjugate TORL-1-23 was safe and tolerable in heavily pretreated, CLDN6-positive advanced solid tumors, including platinum-resistant ovarian cancer. TORL-1-23, a CLDN6 ...